Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$432M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$193M |
| 3 |
iShares MSCI South Korea ETF
EWY
|
+$95.9M |
| 4 |
Molson Coors Class B
TAP
|
+$28.7M |
| 5 |
iShares MSCI Brazil ETF
EWZ
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$172M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$47.9M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$21.1M |
| 4 |
Intel
INTC
|
+$20.4M |
| 5 |
JNPR
Juniper Networks
JNPR
|
+$18.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 2.75% |
| 2 | Technology | 2.62% |
| 3 | Consumer Discretionary | 2.44% |
| 4 | Financials | 1.98% |
| 5 | Healthcare | 1.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NBL
151
DELISTED
Noble Energy, Inc.
NBL
| $4.03M | 0.04% |
105,762
-16,800
| -14% | -$625K |
|
|
QVCGA
152
DELISTED
QVC Group Inc Series A
QVCGA
| $3.72M | 0.04% |
3,836
+3,484
| +990% | +$3.37M |
|
|
BMS
153
DELISTED
Bemis
BMS
| $3.71M | 0.04% |
77,616
+73,116
| +1,625% | +$3.61M |
|
154
Intuit
INTU
$89B
| $3.7M | 0.04% |
+32,300
| New | +$3.62M |
|
|
MRO
155
DELISTED
Marathon Oil Corporation
MRO
| $3.56M | 0.03% |
205,500
-24,700
| -11% | -$397K |
|
156
State Street
STT
$50.7B
| $3.53M | 0.03% |
45,400
+27,600
| +155% | +$2.08M |
|
157
TE Connectivity
TEL
$62.6B
| $3.4M | 0.03% |
49,038
-98,162
| -67% | -$6.5M |
|
158
International Paper
IP
$22B
| $3.33M | 0.03% |
66,337
-119,667
| -64% | -$5.53M |
|
159
Lockheed Martin
LMT
$136B
| $3.27M | 0.03% |
+13,100
| New | +$3.27M |
|
|
PTR
160
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $3.2M | 0.03% |
43,470
-1,486
| -3% | -$105K |
|
161
Kohl's
KSS
$2.19B
| $3.19M | 0.03% |
64,610
-248,526
| -79% | -$12.3M |
|
|
XEC
162
DELISTED
CIMAREX ENERGY CO
XEC
| $3.17M | 0.03% |
23,359
-3,500
| -13% | -$469K |
|
163
Aflac
AFL
$63.4B
| $3.17M | 0.03% |
+91,126
| New | +$3.21M |
|
164
Raymond James Financial
RJF
$34B
| $3.15M | 0.03% |
+68,100
| New | +$3.01M |
|
165
US Bancorp
USB
$99.6B
| $3.13M | 0.03% |
+60,900
| New | +$2.9M |
|
166
Abbott
ABT
$187B
| $3.08M | 0.03% |
80,200
+18,200
| +29% | +$722K |
|
|
TAHO
167
DELISTED
Tahoe Resources Inc
TAHO
| $3.05M | 0.03% |
323,100
+52,800
| +20% | +$550K |
|
168
Affiliated Managers Group
AMG
$9.76B
| $3.01M | 0.03% |
+20,700
| New | +$3.01M |
|
169
Darden Restaurants
DRI
$24.4B
| $2.99M | 0.03% |
41,133
-130,725
| -76% | -$9.09M |
|
170
Teck Resources
TECK
$32.6B
| $2.95M | 0.03% |
147,300
-23,800
| -14% | -$515K |
|
|
AUY
171
DELISTED
Yamana Gold, Inc.
AUY
| $2.94M | 0.03% |
1,046,068
+253,400
| +32% | +$828K |
|
172
Public Service Enterprise Group
PEG
$37.7B
| $2.89M | 0.03% |
65,854
+10,397
| +19% | +$434K |
|
173
EQT Corp
EQT
$32.3B
| $2.86M | 0.03% |
80,435
-19,656
| -20% | -$730K |
|
|
CA
174
DELISTED
CA, Inc.
CA
| $2.86M | 0.03% |
90,100
+25,600
| +40% | +$817K |
|
175
Clorox
CLX
$12.7B
| $2.8M | 0.03% |
23,360
-37,620
| -62% | -$4.44M |
|
Similar funds
Ray Dalio's Q4 2016 Portfolio in Review
As of Q4 2016, Ray Dalio held 377 positions worth $10.5B, up 3.7% from $10.2B the previous quarter. Its ten largest holdings account for 83% of the portfolio.
Ray Dalio deployed $653M of net new capital in Q4 2016, opening 78 new positions and adding to 101 existing holdings. Its largest new stake was UnitedHealth: 163,900 shares worth $26.2M.
By sector, the portfolio is most concentrated in Energy at 2.8% of assets, down from 2.9% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $172M trimmed.
- Ray Dalio's largest Q4 2016 buy was UnitedHealth: 163,900 shares worth $26.2M.
- Ray Dalio added most to Vanguard FTSE Emerging Markets ETF in Q4 2016, an estimated $432M increase.
- Ray Dalio's biggest Q4 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $172M.
- Ray Dalio fully exited Bristol-Myers Squibb in Q4 2016, selling an estimated $21.1M.
- Ray Dalio's ten largest holdings make up 83% of its $10.5B portfolio in Q4 2016.
- Ray Dalio opened 78 new positions and closed 110 in Q4 2016.
- Ray Dalio's portfolio value rose 3.7% quarter-over-quarter to $10.5B.
Based on Bridgewater Associates's 13F filing for Q4 2016, filed 10 Feb 2017.